Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sinikka Green

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2013
Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: efficacy summaryWilliam O'Riordan, Sinikka Green, Purvi Mehra, et al.
Infectious Diseases and Therapy|September 23, 2018
Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical TrialsGregory J Moran, Carisa De Anda, Anita F Das, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2014
Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority studyG Ralph Corey, Samantha Good, Hai Jiang, et al.
International Journal of Antimicrobial Agents|September 26, 2016
Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureusG Ralph Corey, Francis F Arhin, Matthew A Wikler, et al.
The New England Journal of Medicine|February 7, 2019
Omadacycline for Acute Bacterial Skin and Skin-Structure InfectionsWilliam O'Riordan, Sinikka Green, J Scott Overcash, et al.
The New England Journal of Medicine|May 6, 2014
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCVPeter Ferenci, David Bernstein, Jacob Lalezari, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2013
Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: efficacy summaryWilliam O'Riordan, Sinikka Green, Purvi Mehra, et al.
Infectious Diseases and Therapy|September 23, 2018
Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical TrialsGregory J Moran, Carisa De Anda, Anita F Das, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2014
Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority studyG Ralph Corey, Samantha Good, Hai Jiang, et al.
International Journal of Antimicrobial Agents|September 26, 2016
Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureusG Ralph Corey, Francis F Arhin, Matthew A Wikler, et al.
The New England Journal of Medicine|February 7, 2019
Omadacycline for Acute Bacterial Skin and Skin-Structure InfectionsWilliam O'Riordan, Sinikka Green, J Scott Overcash, et al.
The New England Journal of Medicine|May 6, 2014
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCVPeter Ferenci, David Bernstein, Jacob Lalezari, et al.
Pageof 1